skip to main content

CORPORATE PRESENTATION

We invite you to download our corporate presentation to help understand our unique purpose, our current commercial footprint, and our innovative pipeline.

Quarterly Results

2026

Type Title Interactions
Webcast United Therapeutics First Quarter 2026 Financial Results Link
Press Release United Therapeutics Corporation Reports First Quarter 2026 Financial Results Link PDF
SEC Filing Form 10-Q PDF
Presentation United Therapeutics First Quarter 2026 Financial Results Presentation PDF
Fact sheet United Therapeutics First Quarter 2026 Factsheet PDF

2025

Type Title Interactions
Webcast United Therapeutics Fourth Quarter 2025 Financial Results Link
Press Release United Therapeutics Corporation Reports Fourth Quarter and Full Year 2025 Financial Results Link PDF
SEC Filing Form 10-K PDF
Presentation United Therapeutics Fourth Quarter 2025 Financial Results Presentation PDF
Fact sheet United Therapeutics Fourth Quarter 2025 Factsheet PDF
Type Title Interactions
Webcast United Therapeutics Third Quarter 2025 Financial Results Link
Press Release United Therapeutics Corporation Reports Third Quarter 2025 Financial Results Link PDF
SEC Filing Form 10-Q PDF
Presentation United Therapeutics Third Quarter 2025 Financial Results Presentation PDF
Fact sheet United Therapeutics Third Quarter 2025 Factsheet PDF
Type Title Interactions
Webcast United Therapeutics Second Quarter 2025 Financial Results Link
Press Release United Therapeutics Corporation Reports Second Quarter 2025 Financial Results Link PDF
SEC Filing Form 10-Q PDF
Presentation United Therapeutics Second Quarter 2025 Financial Results Presentation PDF
Fact sheet United Therapeutics Second Quarter 2025 Factsheet PDF
Type Title Interactions
Webcast United Therapeutics First Quarter 2025 Financial Results Link
Press Release United Therapeutics Corporation Reports First Quarter 2025 Financial Results Link PDF
SEC Filing Form 10-Q PDF
Presentation United Therapeutics First Quarter 2025 Financial Results Presentation PDF
Fact sheet United Therapeutics First Quarter 2025 Factsheet PDF

2024

Type Title Interactions
Webcast United Therapeutics Fourth Quarter 2024 Financial Results Link
Press Release United Therapeutics Corporation Reports Fourth Quarter and Full Year 2024 Financial Results Link PDF
SEC Filing Form 10-K PDF
Presentation United Therapeutics Fourth Quarter 2024 Financial Results Presentation PDF
Factsheet United Therapeutics Fourth Quarter 2024 Factsheet PDF
Type Title Interactions
Webcast United Therapeutics Third Quarter 2024 Financial Results Link
Press Release United Therapeutics Corporation Reports Third Quarter 2024 Financial Results Link PDF
SEC Filing Form 10-Q PDF
Presentation United Therapeutics Third Quarter 2024 Financial Results Presentation PDF
Factsheet United Therapeutics Third Quarter 2024 Factsheet PDF
Type Title Interactions
Webcast United Therapeutics Second Quarter 2024 Financial Results Link
Press Release United Therapeutics Corporation Reports Second Quarter 2024 Financial Results Link PDF
SEC Filing Form 10-Q PDF
Presentation United Therapeutics Second Quarter 2024 Financial Results Presentation PDF
Type Title Interactions
Webcast United Therapeutics First Quarter 2024 Financial Results Link
Press Release United Therapeutics Corporation Reports First Quarter 2024 Financial Results Link PDF
SEC Filing Form 10-Q PDF
Presentation United Therapeutics First Quarter 2024 Financial Results Presentation PDF

2023

Type Title Interactions
Webcast United Therapeutics Fourth Quarter 2023 Financial Results Link
Press Release United Therapeutics Corporation Reports Fourth Quarter 2023 Financial Results Link PDF
SEC Filing Form 10-K PDF
Presentation United Therapeutics Fourth Quarter 2023 Financial Results Presentation PDF
Type Title Interactions
Webcast United Therapeutics Third Quarter 2023 Financial Results Link
Press Release United Therapeutics Corporation Reports Third Quarter 2023 Financial Results Link PDF
SEC Filing Form 10-Q PDF
Presentation United Therapeutics Third Quarter 2023 Financial Results Presentation PDF
Type Title Interactions
Webcast United Therapeutics Second Quarter 2023 Financial Results Link
Press Release United Therapeutics Corporation Reports Second Quarter 2023 Financial Results Link PDF
SEC Filing Form 10-Q PDF
Type Title Interactions
Webcast United Therapeutics First Quarter 2023 Financial Results Link
Press Release United Therapeutics Corporation Reports First Quarter 2023 Financial Results Link PDF
SEC Filing Form 10-Q PDF

2022

Type Title Interactions
Webcast United Therapeutics Fourth Quarter 2022 Financial Results Link
Press Release United Therapeutics Corporation Reports Fourth Quarter 2022 Financial Results Link PDF
SEC Filing Form 10-K PDF
Type Title Interactions
Webcast United Therapeutics Third Quarter 2022 Financial Results Link
Press Release United Therapeutics Corporation Reports Third Quarter 2022 Financial Results Link PDF
SEC Filing Form 10-Q PDF
Type Title Interactions
Webcast United Therapeutics Second Quarter 2022 Financial Results Link
Press Release United Therapeutics Corporation Reports Second Quarter 2022 Financial Results Link PDF
SEC Filing Form 10-Q PDF
Type Title Interactions
Webcast United Therapeutics First Quarter 2022 Financial Results Link
Press Release United Therapeutics Corporation Reports First Quarter 2022 Financial Results Link PDF
SEC Filing Form 10-Q PDF

2021

Type Title Interactions
Webcast United Therapeutics Fourth Quarter 2021 Financial Results Link
Press Release United Therapeutics Corporation Reports Fourth Quarter 2021 Financial Results Link PDF
SEC Filing Form 10-K PDF
Type Title Interactions
Webcast United Therapeutics Third Quarter 2021 Financial Results Link
Press Release United Therapeutics Corporation Reports Third Quarter 2021 Financial Results Link PDF
SEC Filing Form 10-Q PDF
Type Title Interactions
Webcast United Therapeutics Second Quarter 2021 Financial Results Link
Press Release United Therapeutics Corporation Reports Second Quarter 2021 Financial Results Link PDF
SEC Filing Form 10-Q PDF
Type Title Interactions
Webcast United Therapeutics First Quarter 2021 Financial Results Link
Press Release United Therapeutics Corporation Reports First Quarter 2021 Financial Results Link PDF
SEC Filing Form 10-Q PDF

2020

Type Title Interactions
Webcast United Therapeutics Fourth Quarter 2020 Financial Results Link
Press Release United Therapeutics Corporation Reports Fourth Quarter 2020 Financial Results Link PDF
SEC Filing
Form 10-K PDF
Type Title Interactions
Webcast United Therapeutics Third Quarter 2020 Financial Results Link
Press Release United Therapeutics Corporation Reports Fourth Quarter 2020 Financial Results Link PDF
SEC Filing Form 10-K PDF
Type Title Interactions
Webcast United Therapeutics Second Quarter 2020 Financial Results Link
Press Release United Therapeutics Corporation Reports Second Quarter 2020 Financial Results Link PDF
SEC Filing Form 10-K PDF
Type Title Interactions
Webcast United Therapeutics First Quarter 2020 Financial Results Link
Press Release United Therapeutics Corporation Reports First Quarter 2020 Financial Results Link PDF
SEC Filing Form 10-K PDF

2019

Type Title Interactions
Webcast United Therapeutics Fourth Quarter 2019 Financial Results Link
Press Release United Therapeutics Corporation Reports Fourth Quarter and Full Year 2019 Financial Results Link PDF
SEC Filing Form 10-K PDF
Type Title Interactions
Webcast United Therapeutics Third Quarter 2019 Financial Results Link
Press Release United Therapeutics Corporation Reports Third Quarter 2019 Financial Results Link PDF
SEC Filing Form 10-K PDF
Type Title Interactions
Webcast United Therapeutics Second Quarter 2019 Financial Results Link
Press Release United Therapeutics Corporation Reports Second Quarter 2019 Financial Results Link PDF
SEC Filing Form 10-K PDF
Type Title Interactions
Webcast United Therapeutics First Quarter 2019 Financial Results Link
Press Release United Therapeutics Corporation Reports First Quarter 2019 Financial Results Link PDF
SEC Filing Form 10-K PDF

2018

Type Title Interactions
Webcast United Therapeutics Fourth Quarter 2018 Financial Results Link
Press Release United Therapeutics Corporation Reports 2018 Fourth Quarter And Annual Financial Results Link PDF
SEC Filing Form 10-K PDF
Type Title Interactions
Webcast United Therapeutics Third Quarter 2018 Financial Results Link
Press Release United Therapeutics Corporation Reports Third Quarter 2018 Financial Results Link PDF
SEC Filing Form 10-K PDF
Type Title Interactions
Press Release United Therapeutics Corporation Reports Second Quarter 2018 Financial Results Link PDF
SEC Filing Form 10-K PDF
Type Title Interactions
Press Release United Therapeutics Corporation Reports First Quarter 2018 Financial Results Link PDF
SEC Filing Form 10-K PDF

2017

Type Title Interactions
Press Release United Therapeutics Corporation Reports Second Quarter 2017 Financial Results Link PDF
SEC Filing Form 10-K PDF
Type Title Interactions
Press Release United Therapeutics Corporation Reports Third Quarter 2017 Financial Results Link PDF
SEC Filing Form 10-K PDF
Type Title Interactions
Press Release United Therapeutics Corporation Reports Second Quarter 2017 Financial Results Link PDF
SEC Filing Form 10-K PDF
Type Title Interactions
Press Release United Therapeutics Corporation Reports Second Quarter 2017 Financial Results Link PDF
SEC Filing Form 10-K PDF

2016

Type Title Interactions
Press Release United Therapeutics Corporation Reports Second Quarter 2017 Financial Results Link PDF
SEC Filing Form 10-K PDF
Type Title Interactions
Press Release United Therapeutics Corporation Reports Third Quarter 2016 Financial Results Link PDF
SEC Filing Form 10-K PDF
Type Title Interactions
Press Release United Therapeutics Corporation Reports Second Quarter 2018 Financial Results Link PDF
SEC Filing Form 10-K PDF
Type Title Interactions
Press Release United Therapeutics Corporation Reports First Quarter 2018 Financial Results Link PDF
SEC Filing Form 10-K PDF

2015

Type Title Interactions
Press Release United Therapeutics Corporation Reports Fourth Quarter 2015 Financial Results Link PDF
SEC Filing Form 10-K PDF
Type Title Interactions
Press Release United Therapeutics Corporation Reports Third Quarter 2015 Financial Results Link PDF
SEC Filing Form 10-K PDF
Type Title Interactions
Press Release United Therapeutics Corporation Reports Second Quarter 2015 Financial Results Link PDF
SEC Filing Form 10-K PDF
Type Title Interactions
Press Release United Therapeutics Corporation Reports First Quarter 2015 Financial Results Link PDF
SEC Filing Form 10-K PDF

2014

Type Title Interactions
Press Release United Therapeutics Corporation Reports Fourth Quarter 2014 Financial Results Link PDF
SEC Filing Form 10-K PDF
Type Title Interactions
Press Release United Therapeutics Corporation Reports Third Quarter 2014 Financial Results Link PDF
SEC Filing Form 10-K PDF
Type Title Interactions
Press Release United Therapeutics Corporation Reports Second Quarter 2014 Financial Results Link PDF
SEC Filing Form 10-K PDF
Type Title Interactions
Press Release United Therapeutics Corporation Reports First Quarter 2014 Financial Results Link PDF
SEC Filing Form 10-K PDF

2013

Type Title Interactions
Press Release United Therapeutics Corporation Reports Fourth Quarter 2013 Financial Results Link PDF
SEC Filing Form 10-K PDF
Type Title Interactions
Press Release United Therapeutics Corporation Reports Third Quarter 2013 Financial Results Link PDF
SEC Filing Form 10-K PDF
Type Title Interactions
Press Release United Therapeutics Corporation Reports Second Quarter 2013 Financial Results Link PDF
SEC Filing Form 10-K PDF
Type Title Interactions
Press Release United Therapeutics Corporation Reports First Quarter 2013 Financial Results Link PDF
SEC Filing Form 10-K PDF

2012

Type Title Interactions
Press Release United Therapeutics Corporation Reports Fourth Quarter 2012 Financial Results Link PDF
SEC Filing Form 10-K PDF
Type Title Interactions
Press Release United Therapeutics Corporation Reports Third Quarter 2012 Financial Results Link PDF
SEC Filing Form 10-K PDF
Type Title Interactions
Press Release United Therapeutics Corporation Reports Second Quarter 2012 Financial Results Link PDF
SEC Filing Form 10-K PDF
Type Title Interactions
Press Release United Therapeutics Corporation Reports First Quarter 2012 Financial Results Link PDF
SEC Filing Form 10-K PDF

2011

Type Title Interactions
Press Release United Therapeutics Corporation Reports Fourth Quarter 2011 Financial Results Link PDF
SEC Filing Form 10-K PDF
Type Title Interactions
Press Release United Therapeutics Corporation Reports Third Quarter 2011 Financial Results Link PDF
SEC Filing Form 10-K PDF
Type Title Interactions
Press Release United Therapeutics Corporation Reports Second Quarter 2011 Financial Results Link PDF
SEC Filing Form 10-K PDF
Type Title Interactions
Press Release United Therapeutics Corporation Reports First Quarter 2011 Financial Results Link PDF
SEC Filing Form 10-K PDF

2010

Type Title Interactions
Press Release United Therapeutics Corporation Reports Fourth Quarter 2010 Financial Results Link PDF
SEC Filing Form 10-K PDF
Type Title Interactions
Press Release United Therapeutics Corporation Reports Third Quarter 2010 Financial Results Link PDF
SEC Filing Form 10-K PDF
Type Title Interactions
Press Release United Therapeutics Corporation Reports Second Quarter 2010 Financial Results Link PDF
SEC Filing Form 10-K PDF
Type Title Interactions
Press Release United Therapeutics Corporation Reports First Quarter 2010 Financial Results Link PDF
SEC Filing Form 10-K PDF

2009

Type Title Interactions
Press Release United Therapeutics Corporation Reports Fourth Quarter 2009 Financial Results Link PDF
SEC Filing Form 10-K PDF
Type Title Interactions
Press Release United Therapeutics Corporation Reports Third Quarter 2009 Financial Results Link PDF
SEC Filing Form 10-K PDF
Type Title Interactions
Press Release United Therapeutics Corporation Reports Second Quarter 2009 Financial Results Link PDF
SEC Filing Form 10-K PDF
Type Title Interactions
Press Release United Therapeutics Corporation Reports First Quarter 2009 Financial Results Link PDF
SEC Filing Form 10-K PDF

2008

Type Title Interactions
Press Release United Therapeutics Corporation Reports Fourth Quarter 2008 Financial Results Link PDF
SEC Filing Form 10-K PDF
Type Title Interactions
Press Release United Therapeutics Corporation Reports Third Quarter 2008 Financial Results Link PDF
SEC Filing Form 10-K PDF
Type Title Interactions
Press Release United Therapeutics Corporation Reports Second Quarter 2008 Financial Results Link PDF
SEC Filing Form 10-K PDF
Type Title Interactions
Press Release United Therapeutics Corporation Reports First Quarter 2008 Financial Results Link PDF
SEC Filing Form 10-K PDF

2007

Type Title Interactions
Press Release United Therapeutics Corporation Reports Fourth Quarter 2007 Financial Results Link PDF
SEC Filing Form 10-K PDF
Type Title Interactions
Press Release United Therapeutics Corporation Reports Third Quarter 2007 Financial Results Link PDF
SEC Filing Form 10-K PDF
Type Title Interactions
Press Release United Therapeutics Corporation Reports Second Quarter 2007 Financial Results Link PDF
SEC Filing Form 10-K PDF
Type Title Interactions
Press Release United Therapeutics Corporation Reports First Quarter 2007 Financial Results Link PDF
SEC Filing Form 10-K PDF

2006

Type Title Interactions
Press Release United Therapeutics Corporation Reports Fourth Quarter 2006 Financial Results Link PDF
SEC Filing Form 10-K PDF
Type Title Interactions
Press Release United Therapeutics Corporation Reports Third Quarter 2006 Financial Results Link PDF
SEC Filing Form 10-K PDF
Type Title Interactions
Press Release United Therapeutics Corporation Reports Second Quarter 2006 Financial Results Link PDF
SEC Filing Form 10-K PDF
Type Title Interactions
Press Release United Therapeutics Corporation Reports First Quarter 2006 Financial Results Link PDF
SEC Filing Form 10-K PDF

2005

Type Title Interactions
Press Release United Therapeutics Corporation Reports Third Quarter 2005 Financial Results PDF
SEC Filing Form 10-K PDF
Type Title Interactions
Press Release United Therapeutics Corporation Reports Second Quarter 2005 Financial Results PDF
SEC Filing Form 10-K PDF
Type Title Interactions
Press Release United Therapeutics Corporation Reports First Quarter 2005 Financial Results PDF
SEC Filing Form 10-K PDF

2004

Type Title Interactions
Press Release United Therapeutics Corporation Reports Fourth Quarter 2004 Financial Results PDF
SEC Filing Form 10-K PDF
Type Title Interactions
Press Release United Therapeutics Corporation Reports Third Quarter 2004 Financial Results PDF
SEC Filing Form 10-K PDF
Type Title Interactions
Press Release United Therapeutics Corporation Reports Second Quarter 2004 Financial Results PDF
SEC Filing Form 10-K PDF
Type Title Interactions
Press Release United Therapeutics Corporation Reports First Quarter 2004 Financial Results PDF
SEC Filing Form 10-K PDF

Press Releases

SILVER SPRING, Md. & RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)-- United Therapeutics Corporation (Nasdaq: UTHR) announced today that James Edgemond,Chief Financial Officer and Treasurer, will provide a company...
Presentations of results from the positive TETON phase 3 pivotal studies of inhaled treprostinil in idiopathic pulmonary fibrosis (IPF) include efficacy and safety results from TETON-1 and integrated results from TETON-1...
SILVER SPRING, Md. & RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)-- United Therapeutics Corporation (Nasdaq: UTHR), a public benefit corporation, today announced its financial results for the quarter ended March 31,...
Professor Dwek’s term as a director will conclude at the 2026 Annual Meeting of ShareholdersSILVER SPRING, Md. & RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)-- United Therapeutics Corporation (Nasdaq: UTHR), a...
SILVER SPRING, Md. & RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)-- United Therapeutics Corporation (Nasdaq: UTHR) announced today that it will report its first quarter 2026 financial results in a press release that...
An interim analysis of the PHINDER study identifies non-invasive measures that may facilitate earlier detection and management of pulmonary hypertension (PH) in patients with interstitial lung disease (ILD)An interim...

Events and presentations

19 May 2026

RBC Capital Markets Global Healthcare Conference

09:30 AM ET

06 May 2026

United Therapeutics First Quarter 2026 Financial Results

09:00 AM ET

09 Mar 2026

Leerink Global Healthcare Conference

01:00 PM ET

02 Mar 2026

TD Cowen Health Care Conference

02:30 PM ET

02 Mar 2026

Phase 3 ADVANCE OUTCOMES Clinical Trial Results

08:30 AM ET

25 Feb 2026

United Therapeutics Fourth Quarter and Full Year 2025 Financial Results

09:00 AM ET

SEC Filings

Corporate Annual Reports

PROXY STATEMENTS